Overview

This trial is active, not recruiting.

Condition electromagnetic interference
Treatment electromagnetic field
Sponsor Deutsches Herzzentrum Muenchen
Start date September 2014
End date April 2015
Trial size 100 participants
Trial identifier NCT02252575, GER-EP-014

Summary

E-Transportation is increasing all over the world. It is not known if the used engines interfere with cardiac implantable electronic devices. The study evaluates such potential interferences in vivo.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Endpoint classification safety study
Intervention model single group assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
Exposure to the elctromagnetic field of an electric motor
electromagnetic field
Exposure to the electromagnetic fields of electric motors

Primary Outcomes

Measure
Occurrence of electromagnetic interference
time frame: acute setting

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - implanted cardiac implantable electronic device with regular function Exclusion Criteria: - implanted cardiac implantable electronic device with irregular function

Additional Information

Official title Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices
Description E-Transportation is increasing all over the world. It is not known if the used engines interfere with cardiac implantable electronic devices. The study evaluates different types of electric motors with regard to electromagnetic interference with implanted pacemakers or cardioverter-defibrillators.
Trial information was received from ClinicalTrials.gov and was last updated in June 2015.
Information provided to ClinicalTrials.gov by Deutsches Herzzentrum Muenchen.